People In The News | GenomeWeb

People In The News

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – BioMarker Strategies has named Samuel Broder, Mark Velleca, and Paul Beresford to its board of directors. Broder was VP and CMO at Celera for a dozen years, and he is a former director of the National Cancer Institute. Velleca founded and was VP of CGI Pharmaceuticals. Beresford currently is VP of business development at Biodesix, and he formerly was VP of translational diagnostics at Ventana Medical Systems.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PLOS this week: role for Notch signaling in congenital heart disease, sciatica risk variants, and more.

Researchers in China have used the CRISPR/Cas9 genome editing approach to alter the length of hair fibers in cashmere goats.

According to ScienceInsider, the Scripps Research Institute and the California Institute for Biomedical Research are merging.

National Cancer Institute researchers didn't report severe adverse events to Food and Drug Administration in a timely manner, the Wall Street Journal reports.